Gruechem, founded in 2011, specializes in the custom production and synthesis of foundational units, core structures, and molecular frameworks primarily utilized in the research and development of novel medications. The company has developed an advanced technology platform and possesses effective analysis techniques, allowing them to offer products ranging from small to large-scale manufacturing, including sophisticated pharmaceutical intermediates, core molecular structures, distinct building blocks, specialty chemicals, and original brand reagents.